Literature DB >> 16670329

TLR5-mediated phosphoinositide 3-kinase activation negatively regulates flagellin-induced proinflammatory gene expression.

Yimin Yu1, Shigenori Nagai, Huixia Wu, Andrew S Neish, Shigeo Koyasu, Andrew T Gewirtz.   

Abstract

Epithelial cells detect motile pathogens via TLR5 ligation of flagellin, resulting in rapid induction of antibacterial/proinflammatory gene expression. Although such flagellin-induced gene expression is quite transient, likely to avoid the negative consequences of inflammation, little is known regarding the molecular mechanisms that mediate its shutdown. We hypothesized that, analogous to the case for TLR4, phosphoinositide 3-kinase (PI3K) might negatively regulate TLR5 signaling. However, because PI3K is an essential positive mediator of some pathways of TLR-mediated gene expression, the opposite hypothesis was also considered. Herein, we observed that flagellin stimulation of epithelial cells indeed induced rapid (<30 min) PI3K activation, as evidenced by Akt phosphorylation, via a TLR5-mediated mechanism. Blockade of PI3K with wortmannin resulted in marked enhancement of flagellin-induced gene expression as assessed by measuring levels of inducible NO synthase, IL-6, and IL-8. Such enhancement of gene expression by PI3K inhibition correlated with prolonged activation of MAPK (p38 and ERK1/2) and was ablated under MAPK inhibition. Such effect of inhibiting PI3K with wortmannin was mimicked by the PI3K inhibitor LY294002, and, conversely, a constitutively active PI3K prevented p38 activation in response to flagellin. Last, to test the significance of these results in vivo, we measured flagellin-induced gene expression in PI3K knockout mice. PI3K-null mice displayed increased levels of flagellin-induced serum IL-6, KC (IL-8 homolog), and nitrite as compared with heterozygous littermates. Thus, TLR5's rapid activation of PI3K serves to limit MAPK signaling, thus limiting proinflammatory gene expression and reducing the potential negative consequences of proinflammatory gene expression.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16670329     DOI: 10.4049/jimmunol.176.10.6194

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  41 in total

1.  TLR5, a novel and unidentified inflammatory mediator in rheumatoid arthritis that correlates with disease activity score and joint TNF-α levels.

Authors:  Nathan D Chamberlain; Olga M Vila; Michael V Volin; Suncica Volkov; Richard M Pope; William Swedler; Arthur M Mandelin; Shiva Shahrara
Journal:  J Immunol       Date:  2012-06-01       Impact factor: 5.422

Review 2.  Toll like receptor-5: protecting the gut from enteric microbes.

Authors:  Matam Vijay-Kumar; Jesse D Aitken; Andrew T Gewirtz
Journal:  Semin Immunopathol       Date:  2007-12-07       Impact factor: 9.623

3.  TLR4/MyD88/PI3K interactions regulate TLR4 signaling.

Authors:  Michelle H W Laird; Sang Hoon Rhee; Darren J Perkins; Andrei E Medvedev; Wenji Piao; Matthew J Fenton; Stefanie N Vogel
Journal:  J Leukoc Biol       Date:  2009-03-16       Impact factor: 4.962

4.  Mucosal adjuvant activity of flagellin in aged mice.

Authors:  John T Bates; Anna N Honko; Aaron H Graff; Nancy D Kock; Steven B Mizel
Journal:  Mech Ageing Dev       Date:  2008-02-17       Impact factor: 5.432

Review 5.  Cellular and molecular biology of airway mucins.

Authors:  Erik P Lillehoj; Kosuke Kato; Wenju Lu; Kwang C Kim
Journal:  Int Rev Cell Mol Biol       Date:  2013       Impact factor: 6.813

6.  Effects of cigarette smoke on Toll-like receptor (TLR) activation of chronic obstructive pulmonary disease (COPD) macrophages.

Authors:  H J Metcalfe; S Lea; D Hughes; R Khalaf; K Abbott-Banner; D Singh
Journal:  Clin Exp Immunol       Date:  2014-06       Impact factor: 4.330

Review 7.  Toll-like receptor signaling in cell proliferation and survival.

Authors:  Xinyan Li; Song Jiang; Richard I Tapping
Journal:  Cytokine       Date:  2009-09-22       Impact factor: 3.861

8.  Tumor suppressor Foxo3a is involved in the regulation of lipopolysaccharide-induced interleukin-8 in intestinal HT-29 cells.

Authors:  Lobke Snoeks; Christopher R Weber; Jerrold R Turner; Mitra Bhattacharyya; Kaarin Wasland; Suzana D Savkovic
Journal:  Infect Immun       Date:  2008-08-04       Impact factor: 3.441

Review 9.  Toll-like receptors in inflammatory bowel diseases: a decade later.

Authors:  Elke Cario
Journal:  Inflamm Bowel Dis       Date:  2010-09       Impact factor: 5.325

10.  The p110α and p110β isoforms of class I phosphatidylinositol 3-kinase are involved in toll-like receptor 5 signaling in epithelial cells.

Authors:  Sabine M Ivison; Mohammed A S Khan; Nicholas R Graham; Leila A Shobab; Yu Yao; Arnawaz Kifayet; Laura M Sly; Theodore S Steiner
Journal:  Mediators Inflamm       Date:  2010-10-03       Impact factor: 4.711

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.